Preparation and bioevaluation of [99mTc]Tc-labeled A7R and DA7R for SPECT imaging of triple-negative breast cancer. (31st October 2022)
- Record Type:
- Journal Article
- Title:
- Preparation and bioevaluation of [99mTc]Tc-labeled A7R and DA7R for SPECT imaging of triple-negative breast cancer. (31st October 2022)
- Main Title:
- Preparation and bioevaluation of [99mTc]Tc-labeled A7R and DA7R for SPECT imaging of triple-negative breast cancer
- Authors:
- Su, Hongxing
Zhao, Lingzhou
Yu, Buhui
Zeng, Huahui
Yang, Jiqin
Zhu, Meilin
Zhao, Jinhua - Abstract:
- Abstract : [ 99m Tc]Tc-labeled D-type A7R peptide showed better tumor-to-muscle ratios and lower renal uptake. Abstract : Novel strategies for diagnosing triple-negative breast cancer (TNBC) are essential for effective clinical treatment. Vascular endothelial growth factor receptor 2 (VEGFR2) and neuropilin-1 (NRP-1) are potential targets for tumor imaging agents. We designed and synthesized [ 99m Tc]Tc-labeled heptapeptide (A7R) and its D-type peptide ( D A7R) with high affinity and specificity for VEGFR2 and NRP-1 as novel single-photon emission computed tomography (SPECT) probes for TNBC imaging. The specificities of A7R and D A7R were first evaluated in vitro using flow cytometry and confocal microscopy and ex vivo using fluorescence imaging. Subsequently, A7R and D A7R were labeled with [ 99m Tc]Tc through 6-hydrazino nicotinamide (HYNIC), and their radiochemical purities (RCPs) and stability in vitro were assessed. The imaging performance and biodistribution of [ 99m Tc]Tc-HYNIC-A7R and [ 99m Tc]Tc-HYNIC- D A7R were evaluated in TNBC mouse models. A7R and D A7R exhibited good TNBC cell-targeting abilities and were readily labeled with [ 99m Tc]Tc through HYNIC. Both [ 99m Tc]Tc-HYNIC-A7R and [ 99m Tc]Tc-HYNIC- D A7R had high RCPs and stability in vitro, and their accumulation in tumor tissues in the TNBC models was evident, with fast blood clearance and favorable biodistribution. More importantly, [ 99m Tc]Tc-HYNIC- D A7R showed better tumor-to-muscle ratios and lowerAbstract : [ 99m Tc]Tc-labeled D-type A7R peptide showed better tumor-to-muscle ratios and lower renal uptake. Abstract : Novel strategies for diagnosing triple-negative breast cancer (TNBC) are essential for effective clinical treatment. Vascular endothelial growth factor receptor 2 (VEGFR2) and neuropilin-1 (NRP-1) are potential targets for tumor imaging agents. We designed and synthesized [ 99m Tc]Tc-labeled heptapeptide (A7R) and its D-type peptide ( D A7R) with high affinity and specificity for VEGFR2 and NRP-1 as novel single-photon emission computed tomography (SPECT) probes for TNBC imaging. The specificities of A7R and D A7R were first evaluated in vitro using flow cytometry and confocal microscopy and ex vivo using fluorescence imaging. Subsequently, A7R and D A7R were labeled with [ 99m Tc]Tc through 6-hydrazino nicotinamide (HYNIC), and their radiochemical purities (RCPs) and stability in vitro were assessed. The imaging performance and biodistribution of [ 99m Tc]Tc-HYNIC-A7R and [ 99m Tc]Tc-HYNIC- D A7R were evaluated in TNBC mouse models. A7R and D A7R exhibited good TNBC cell-targeting abilities and were readily labeled with [ 99m Tc]Tc through HYNIC. Both [ 99m Tc]Tc-HYNIC-A7R and [ 99m Tc]Tc-HYNIC- D A7R had high RCPs and stability in vitro, and their accumulation in tumor tissues in the TNBC models was evident, with fast blood clearance and favorable biodistribution. More importantly, [ 99m Tc]Tc-HYNIC- D A7R showed better tumor-to-muscle ratios and lower renal uptake than [ 99m Tc]Tc-HYNIC-A7R. These results suggest that both [ 99m Tc]Tc-HYNIC- D A7R and [ 99m Tc]Tc-HYNIC-A7R have substantial potential as probes for targeted SPECT imaging of TNBC, and the former may be considered for future clinical translation owing to its superior tumor imaging performance. … (more)
- Is Part Of:
- New journal of chemistry. Volume 46:Number 44(2022)
- Journal:
- New journal of chemistry
- Issue:
- Volume 46:Number 44(2022)
- Issue Display:
- Volume 46, Issue 44 (2022)
- Year:
- 2022
- Volume:
- 46
- Issue:
- 44
- Issue Sort Value:
- 2022-0046-0044-0000
- Page Start:
- 21401
- Page End:
- 21408
- Publication Date:
- 2022-10-31
- Subjects:
- Chemistry -- Periodicals
Chimie -- Périodiques
540 - Journal URLs:
- http://www.rsc.org/ ↗
http://www.rsc.org/is/journals/current/newjchem/njc.htm ↗ - DOI:
- 10.1039/d2nj04136g ↗
- Languages:
- English
- ISSNs:
- 1144-0546
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6084.319900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24497.xml